The American Journal of Managed Care4d
Study Finds Declining SCLC Incidence, but Stagnant Survival Rates
SEER data show that small cell lung cancer (SCLS) incidence has steadily declined due to reduced smoking rates, but survival outcomes have seen only minimal improvement, underscoring the need for more ...
Targeted Oncology4d
FDA Grants 225Ac-SSO110 Orphan Drug Status in SCLC
Ac-SSO110 has now received FDA orphan drug designation and investigational new drug application clearance for the treatment ...
Hosted on MSN2mon
FDA approves AstraZeneca’s Imfinzi to treat LS-SCLC
The US Food and Drug Administration (FDA) has approved AstraZeneca's human monoclonal antibody, Imfinzi (durvalumab), to treat limited-stage small cell lung cancer (LS-SCLC) in the adult population.
The Roanoke Times24d
King's message from decades ago still timely, relevant, SCLC speaker says
Davis was the keynote speaker at the Roanoke Chapter of the Southern Christian Leadership Conference’s 28th annual luncheon organized to celebrate King’s life and legacy as the nation marks a ...
emjreviews.com7d
LS-SCLC Immunotherapy Treatment Recommended for Approval
Immunotherapy has shown a 27% reduction in mortality for patients with limited-stage small cell lung cancer, based on Phase ...
Longview News-Journal1mon
Local advocates bring Southern Christian Leadership Conference chapter to Columbia
Mid-Missouri’s first Southern Christian Leadership Conference chapter is holding its inaugural summit Jan. 17-19. In the days leading up to Martin Luther King Jr. Day, the chapter will honor the ...
Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Shanghai Henlius Biotech, Inc. (2696.HK) announced that its anti-PD-1 mAb, HANSIZHUANG (serplulimab, marketed as Hetronifly® in Europe), has been officially approved by the European Commission (EC) ...
The American Journal of Managed Care27d
FDA Proposal Aims to Reduce Smoking Addiction and SCLC Cases
Small cell lung cancer (SCLC) is strongly linked to smoking, with about 80% of lung cancer deaths attributed to tobacco use. This article has been updated. The FDA has announced a landmark ...
Business Wire20d
Zai Lab Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the Treatment of Small Cell Lung Cancer (SCLC)
“Receiving an Orphan Drug Designation for ZL-1310 recognizes its potential to treat patients with SCLC. These patients have an urgent need for innovative treatment options with improved ...
Pharm Exec13d
ADRIATIC Trial Demonstrates Significant Survival Benefit in LS-SCLC, Potentially Shaping Future Treatment Standards
Nancy Ghattas, VP, US franchise head, imunno-oncology, gastrointestinal tumors, AstraZeneca, discusses the promising results from the ADRIATIC trial, in which patients were treated with Imfinzi for ...
The Victoria Advocate7d
Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Serplulimab was granted orphan drug designations by the FDA and the EC for the treatment of SCLC, and its bridging head-to-head trial in the United States to compare HANSIZHUANG to standard of ...